nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorprothixene—DRD3—Parkinson's disease	0.219	0.281	CbGaD
Chlorprothixene—DRD1—Parkinson's disease	0.214	0.276	CbGaD
Chlorprothixene—DRD2—Parkinson's disease	0.151	0.194	CbGaD
Chlorprothixene—HTR2A—Parkinson's disease	0.117	0.15	CbGaD
Chlorprothixene—ABCB1—Parkinson's disease	0.0763	0.0981	CbGaD
Chlorprothixene—DRD3—telencephalic ventricle—Parkinson's disease	0.00496	0.0619	CbGeAlD
Chlorprothixene—HTR2A—enteric nervous system—Parkinson's disease	0.00442	0.0552	CbGeAlD
Chlorprothixene—DRD1—telencephalic ventricle—Parkinson's disease	0.00355	0.0443	CbGeAlD
Chlorprothixene—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00335	0.0418	CbGeAlD
Chlorprothixene—HTR2A—locus ceruleus—Parkinson's disease	0.00292	0.0364	CbGeAlD
Chlorprothixene—HTR2C—telencephalic ventricle—Parkinson's disease	0.00276	0.0344	CbGeAlD
Chlorprothixene—HTR2A—cerebellar cortex—Parkinson's disease	0.00238	0.0297	CbGeAlD
Chlorprothixene—HTR2A—sympathetic nervous system—Parkinson's disease	0.00231	0.0288	CbGeAlD
Chlorprothixene—DRD1—nerve—Parkinson's disease	0.00224	0.0279	CbGeAlD
Chlorprothixene—DRD2—telencephalic ventricle—Parkinson's disease	0.0021	0.0262	CbGeAlD
Chlorprothixene—HTR2A—pons—Parkinson's disease	0.00168	0.021	CbGeAlD
Chlorprothixene—HTR2A—autonomic nervous system—Parkinson's disease	0.00155	0.0194	CbGeAlD
Chlorprothixene—HTR2A—telencephalic ventricle—Parkinson's disease	0.00138	0.0173	CbGeAlD
Chlorprothixene—DRD2—nerve—Parkinson's disease	0.00132	0.0165	CbGeAlD
Chlorprothixene—HTR6—forebrain—Parkinson's disease	0.00125	0.0156	CbGeAlD
Chlorprothixene—HTR2A—peripheral nervous system—Parkinson's disease	0.00112	0.014	CbGeAlD
Chlorprothixene—DRD2—hindbrain—Parkinson's disease	0.00099	0.0124	CbGeAlD
Chlorprothixene—DRD1—brainstem—Parkinson's disease	0.00096	0.012	CbGeAlD
Chlorprothixene—DRD1—forebrain—Parkinson's disease	0.000927	0.0116	CbGeAlD
Chlorprothixene—HTR2A—nerve—Parkinson's disease	0.000872	0.0109	CbGeAlD
Chlorprothixene—CHRM4—head—Parkinson's disease	0.000797	0.00996	CbGeAlD
Chlorprothixene—CHRM4—nervous system—Parkinson's disease	0.000756	0.00944	CbGeAlD
Chlorprothixene—CHRM2—forebrain—Parkinson's disease	0.000747	0.00933	CbGeAlD
Chlorprothixene—HTR2C—brainstem—Parkinson's disease	0.000746	0.00932	CbGeAlD
Chlorprothixene—DRD3—head—Parkinson's disease	0.000741	0.00926	CbGeAlD
Chlorprothixene—CHRM4—central nervous system—Parkinson's disease	0.000728	0.00909	CbGeAlD
Chlorprothixene—HTR2C—forebrain—Parkinson's disease	0.00072	0.00899	CbGeAlD
Chlorprothixene—HTR6—head—Parkinson's disease	0.000713	0.00891	CbGeAlD
Chlorprothixene—DRD3—nervous system—Parkinson's disease	0.000703	0.00878	CbGeAlD
Chlorprothixene—CHRM1—forebrain—Parkinson's disease	0.00068	0.00849	CbGeAlD
Chlorprothixene—DRD3—central nervous system—Parkinson's disease	0.000677	0.00845	CbGeAlD
Chlorprothixene—HTR6—nervous system—Parkinson's disease	0.000676	0.00845	CbGeAlD
Chlorprothixene—HTR2B—forebrain—Parkinson's disease	0.000676	0.00845	CbGeAlD
Chlorprothixene—HTR2A—hindbrain—Parkinson's disease	0.000653	0.00816	CbGeAlD
Chlorprothixene—HTR6—central nervous system—Parkinson's disease	0.000651	0.00814	CbGeAlD
Chlorprothixene—CHRM2—cardiovascular system—Parkinson's disease	0.000632	0.00789	CbGeAlD
Chlorprothixene—CHRM5—head—Parkinson's disease	0.000623	0.00778	CbGeAlD
Chlorprothixene—DRD1—midbrain—Parkinson's disease	0.000612	0.00765	CbGeAlD
Chlorprothixene—CHRM3—forebrain—Parkinson's disease	0.000608	0.0076	CbGeAlD
Chlorprothixene—CHRM5—nervous system—Parkinson's disease	0.000591	0.00738	CbGeAlD
Chlorprothixene—CHRM4—brain—Parkinson's disease	0.000578	0.00722	CbGeAlD
Chlorprothixene—CHRM1—cardiovascular system—Parkinson's disease	0.000575	0.00718	CbGeAlD
Chlorprothixene—HTR2B—cardiovascular system—Parkinson's disease	0.000572	0.00714	CbGeAlD
Chlorprothixene—CHRM5—central nervous system—Parkinson's disease	0.000569	0.00711	CbGeAlD
Chlorprothixene—DRD2—brainstem—Parkinson's disease	0.000567	0.00709	CbGeAlD
Chlorprothixene—DRD2—forebrain—Parkinson's disease	0.000548	0.00684	CbGeAlD
Chlorprothixene—DRD3—brain—Parkinson's disease	0.000537	0.00671	CbGeAlD
Chlorprothixene—DRD1—head—Parkinson's disease	0.000531	0.00663	CbGeAlD
Chlorprothixene—HTR2C—medulla oblongata—Parkinson's disease	0.00052	0.0065	CbGeAlD
Chlorprothixene—HTR6—brain—Parkinson's disease	0.000517	0.00646	CbGeAlD
Chlorprothixene—DRD1—nervous system—Parkinson's disease	0.000503	0.00629	CbGeAlD
Chlorprothixene—DRD1—central nervous system—Parkinson's disease	0.000484	0.00605	CbGeAlD
Chlorprothixene—HTR2C—midbrain—Parkinson's disease	0.000475	0.00594	CbGeAlD
Chlorprothixene—HTR2C—spinal cord—Parkinson's disease	0.000464	0.00579	CbGeAlD
Chlorprothixene—CHRM5—brain—Parkinson's disease	0.000452	0.00564	CbGeAlD
Chlorprothixene—HRH1—forebrain—Parkinson's disease	0.000432	0.0054	CbGeAlD
Chlorprothixene—CHRM2—head—Parkinson's disease	0.000428	0.00534	CbGeAlD
Chlorprothixene—HTR2C—head—Parkinson's disease	0.000412	0.00515	CbGeAlD
Chlorprothixene—HTR2A—embryo—Parkinson's disease	0.000408	0.0051	CbGeAlD
Chlorprothixene—CHRM2—nervous system—Parkinson's disease	0.000406	0.00507	CbGeAlD
Chlorprothixene—HTR2C—nervous system—Parkinson's disease	0.000391	0.00488	CbGeAlD
Chlorprothixene—CHRM2—central nervous system—Parkinson's disease	0.00039	0.00488	CbGeAlD
Chlorprothixene—CHRM1—head—Parkinson's disease	0.000389	0.00486	CbGeAlD
Chlorprothixene—HTR2B—head—Parkinson's disease	0.000387	0.00484	CbGeAlD
Chlorprothixene—DRD1—brain—Parkinson's disease	0.000385	0.0048	CbGeAlD
Chlorprothixene—HTR2C—central nervous system—Parkinson's disease	0.000376	0.0047	CbGeAlD
Chlorprothixene—HTR2A—brainstem—Parkinson's disease	0.000374	0.00467	CbGeAlD
Chlorprothixene—CHRM1—nervous system—Parkinson's disease	0.000369	0.00461	CbGeAlD
Chlorprothixene—HTR2B—nervous system—Parkinson's disease	0.000367	0.00459	CbGeAlD
Chlorprothixene—DRD2—midbrain—Parkinson's disease	0.000362	0.00452	CbGeAlD
Chlorprothixene—HTR2A—forebrain—Parkinson's disease	0.000361	0.00451	CbGeAlD
Chlorprothixene—CHRM1—central nervous system—Parkinson's disease	0.000355	0.00444	CbGeAlD
Chlorprothixene—HTR2B—central nervous system—Parkinson's disease	0.000353	0.00442	CbGeAlD
Chlorprothixene—CHRM3—head—Parkinson's disease	0.000348	0.00435	CbGeAlD
Chlorprothixene—CHRM3—nervous system—Parkinson's disease	0.00033	0.00413	CbGeAlD
Chlorprothixene—CHRM3—central nervous system—Parkinson's disease	0.000318	0.00397	CbGeAlD
Chlorprothixene—DRD2—head—Parkinson's disease	0.000314	0.00392	CbGeAlD
Chlorprothixene—CHRM2—brain—Parkinson's disease	0.00031	0.00387	CbGeAlD
Chlorprothixene—HTR2A—cardiovascular system—Parkinson's disease	0.000305	0.00382	CbGeAlD
Chlorprothixene—HTR2C—brain—Parkinson's disease	0.000299	0.00373	CbGeAlD
Chlorprothixene—DRD2—nervous system—Parkinson's disease	0.000297	0.00371	CbGeAlD
Chlorprothixene—DRD2—central nervous system—Parkinson's disease	0.000286	0.00358	CbGeAlD
Chlorprothixene—CHRM1—brain—Parkinson's disease	0.000282	0.00352	CbGeAlD
Chlorprothixene—HTR2B—brain—Parkinson's disease	0.000281	0.00351	CbGeAlD
Chlorprothixene—DRD2—cerebellum—Parkinson's disease	0.00028	0.00349	CbGeAlD
Chlorprothixene—ABCB1—embryo—Parkinson's disease	0.000268	0.00334	CbGeAlD
Chlorprothixene—HTR2A—medulla oblongata—Parkinson's disease	0.000261	0.00326	CbGeAlD
Chlorprothixene—CHRM3—brain—Parkinson's disease	0.000252	0.00315	CbGeAlD
Chlorprothixene—HRH1—head—Parkinson's disease	0.000248	0.00309	CbGeAlD
Chlorprothixene—HTR2A—midbrain—Parkinson's disease	0.000238	0.00298	CbGeAlD
Chlorprothixene—ABCB1—forebrain—Parkinson's disease	0.000237	0.00296	CbGeAlD
Chlorprothixene—HRH1—nervous system—Parkinson's disease	0.000235	0.00293	CbGeAlD
Chlorprothixene—HTR2A—spinal cord—Parkinson's disease	0.000233	0.00291	CbGeAlD
Chlorprothixene—DRD2—brain—Parkinson's disease	0.000227	0.00284	CbGeAlD
Chlorprothixene—HRH1—central nervous system—Parkinson's disease	0.000226	0.00282	CbGeAlD
Chlorprothixene—HTR2A—head—Parkinson's disease	0.000207	0.00258	CbGeAlD
Chlorprothixene—ABCB1—cardiovascular system—Parkinson's disease	0.0002	0.0025	CbGeAlD
Chlorprothixene—HTR2A—nervous system—Parkinson's disease	0.000196	0.00245	CbGeAlD
Chlorprothixene—HTR2A—central nervous system—Parkinson's disease	0.000189	0.00236	CbGeAlD
Chlorprothixene—HTR2A—cerebellum—Parkinson's disease	0.000185	0.0023	CbGeAlD
Chlorprothixene—HRH1—brain—Parkinson's disease	0.000179	0.00224	CbGeAlD
Chlorprothixene—ABCB1—medulla oblongata—Parkinson's disease	0.000171	0.00214	CbGeAlD
Chlorprothixene—Zuclopenthixol—DRD1—Parkinson's disease	0.000167	0.0247	CrCbGaD
Chlorprothixene—Triflupromazine—DRD1—Parkinson's disease	0.000162	0.0239	CrCbGaD
Chlorprothixene—ABCB1—midbrain—Parkinson's disease	0.000156	0.00195	CbGeAlD
Chlorprothixene—ABCB1—spinal cord—Parkinson's disease	0.000152	0.0019	CbGeAlD
Chlorprothixene—Clomipramine—GSTP1—Parkinson's disease	0.000151	0.0223	CrCbGaD
Chlorprothixene—Acepromazine—DRD1—Parkinson's disease	0.00015	0.0221	CrCbGaD
Chlorprothixene—HTR2A—brain—Parkinson's disease	0.00015	0.00187	CbGeAlD
Chlorprothixene—Thiothixene—DRD1—Parkinson's disease	0.000144	0.0213	CrCbGaD
Chlorprothixene—Chlorphenamine—SLC6A3—Parkinson's disease	0.000144	0.0212	CrCbGaD
Chlorprothixene—Prochlorperazine—DRD3—Parkinson's disease	0.00014	0.0207	CrCbGaD
Chlorprothixene—ABCB1—head—Parkinson's disease	0.000136	0.00169	CbGeAlD
Chlorprothixene—ABCB1—nervous system—Parkinson's disease	0.000128	0.00161	CbGeAlD
Chlorprothixene—Cyamemazine—HTR2A—Parkinson's disease	0.000127	0.0188	CrCbGaD
Chlorprothixene—Acepromazine—HTR1A—Parkinson's disease	0.000125	0.0184	CrCbGaD
Chlorprothixene—ABCB1—central nervous system—Parkinson's disease	0.000124	0.00155	CbGeAlD
Chlorprothixene—Carbinoxamine—CYP2E1—Parkinson's disease	0.000121	0.0179	CrCbGaD
Chlorprothixene—ABCB1—cerebellum—Parkinson's disease	0.000121	0.00151	CbGeAlD
Chlorprothixene—Propiomazine—DRD1—Parkinson's disease	0.00012	0.0177	CrCbGaD
Chlorprothixene—Thiothixene—HTR1A—Parkinson's disease	0.00012	0.0177	CrCbGaD
Chlorprothixene—Cyclobenzaprine—HTR2A—Parkinson's disease	0.000118	0.0175	CrCbGaD
Chlorprothixene—Zuclopenthixol—DRD2—Parkinson's disease	0.000118	0.0174	CrCbGaD
Chlorprothixene—Triflupromazine—DRD2—Parkinson's disease	0.000114	0.0169	CrCbGaD
Chlorprothixene—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.000108	0.016	CrCbGaD
Chlorprothixene—Perphenazine—HTR7—Parkinson's disease	0.000107	0.0158	CrCbGaD
Chlorprothixene—Acepromazine—DRD2—Parkinson's disease	0.000106	0.0156	CrCbGaD
Chlorprothixene—Methotrimeprazine—DRD3—Parkinson's disease	0.000104	0.0154	CrCbGaD
Chlorprothixene—Methotrimeprazine—DRD1—Parkinson's disease	0.000103	0.0151	CrCbGaD
Chlorprothixene—Thiothixene—DRD2—Parkinson's disease	0.000102	0.015	CrCbGaD
Chlorprothixene—Perphenazine—DRD1—Parkinson's disease	9.86e-05	0.0146	CrCbGaD
Chlorprothixene—ABCB1—brain—Parkinson's disease	9.82e-05	0.00123	CbGeAlD
Chlorprothixene—Prochlorperazine—DRD2—Parkinson's disease	9.72e-05	0.0143	CrCbGaD
Chlorprothixene—Nortriptyline—HTR1A—Parkinson's disease	9.25e-05	0.0137	CrCbGaD
Chlorprothixene—Zuclopenthixol—HTR2A—Parkinson's disease	9.11e-05	0.0135	CrCbGaD
Chlorprothixene—Carbinoxamine—CYP2D6—Parkinson's disease	8.89e-05	0.0131	CrCbGaD
Chlorprothixene—Promazine—DRD1—Parkinson's disease	8.89e-05	0.0131	CrCbGaD
Chlorprothixene—Chlordiazepoxide—CYP2D6—Parkinson's disease	8.48e-05	0.0125	CrCbGaD
Chlorprothixene—Chlorpromazine—HTR7—Parkinson's disease	8.47e-05	0.0125	CrCbGaD
Chlorprothixene—Propiomazine—DRD2—Parkinson's disease	8.45e-05	0.0125	CrCbGaD
Chlorprothixene—Amitriptyline—HTR7—Parkinson's disease	8.38e-05	0.0124	CrCbGaD
Chlorprothixene—Zuclopenthixol—CYP2D6—Parkinson's disease	8.34e-05	0.0123	CrCbGaD
Chlorprothixene—Doxepin—HTR1A—Parkinson's disease	8.3e-05	0.0123	CrCbGaD
Chlorprothixene—Perphenazine—HTR1A—Parkinson's disease	8.19e-05	0.0121	CrCbGaD
Chlorprothixene—Acepromazine—HTR2A—Parkinson's disease	8.17e-05	0.0121	CrCbGaD
Chlorprothixene—Chlorpromazine—DRD3—Parkinson's disease	7.97e-05	0.0118	CrCbGaD
Chlorprothixene—Amitriptyline—DRD3—Parkinson's disease	7.88e-05	0.0116	CrCbGaD
Chlorprothixene—Thiothixene—HTR2A—Parkinson's disease	7.86e-05	0.0116	CrCbGaD
Chlorprothixene—Nortriptyline—DRD2—Parkinson's disease	7.85e-05	0.0116	CrCbGaD
Chlorprothixene—Chlorpromazine—DRD1—Parkinson's disease	7.82e-05	0.0115	CrCbGaD
Chlorprothixene—Chlorphenamine—CYP2D6—Parkinson's disease	7.56e-05	0.0112	CrCbGaD
Chlorprothixene—Nortriptyline—CYP2E1—Parkinson's disease	7.56e-05	0.0112	CrCbGaD
Chlorprothixene—Methotrimeprazine—DRD2—Parkinson's disease	7.23e-05	0.0107	CrCbGaD
Chlorprothixene—Flurazepam—CYP2E1—Parkinson's disease	7.19e-05	0.0106	CrCbGaD
Chlorprothixene—Thiothixene—CYP2D6—Parkinson's disease	7.19e-05	0.0106	CrCbGaD
Chlorprothixene—Promethazine—DRD2—Parkinson's disease	7.12e-05	0.0105	CrCbGaD
Chlorprothixene—Doxepin—DRD2—Parkinson's disease	7.05e-05	0.0104	CrCbGaD
Chlorprothixene—Methotrimeprazine—CYP2E1—Parkinson's disease	6.96e-05	0.0103	CrCbGaD
Chlorprothixene—Perphenazine—DRD2—Parkinson's disease	6.95e-05	0.0103	CrCbGaD
Chlorprothixene—Prochlorperazine—CYP2D6—Parkinson's disease	6.87e-05	0.0101	CrCbGaD
Chlorprothixene—Midazolam—CYP2E1—Parkinson's disease	6.67e-05	0.00984	CrCbGaD
Chlorprothixene—Propiomazine—HTR2A—Parkinson's disease	6.53e-05	0.00964	CrCbGaD
Chlorprothixene—Chlorpromazine—HTR1A—Parkinson's disease	6.49e-05	0.00959	CrCbGaD
Chlorprothixene—Amitriptyline—HTR1A—Parkinson's disease	6.42e-05	0.00948	CrCbGaD
Chlorprothixene—Promazine—DRD2—Parkinson's disease	6.26e-05	0.00925	CrCbGaD
Chlorprothixene—Clomipramine—HTR2A—Parkinson's disease	6.21e-05	0.00917	CrCbGaD
Chlorprothixene—Nortriptyline—HTR2A—Parkinson's disease	6.07e-05	0.00896	CrCbGaD
Chlorprothixene—Triflupromazine—ABCB1—Parkinson's disease	5.77e-05	0.00851	CrCbGaD
Chlorprothixene—Diazepam—CYP2E1—Parkinson's disease	5.71e-05	0.00843	CrCbGaD
Chlorprothixene—Clomipramine—CYP2D6—Parkinson's disease	5.68e-05	0.00839	CrCbGaD
Chlorprothixene—Methotrimeprazine—HTR2A—Parkinson's disease	5.59e-05	0.00825	CrCbGaD
Chlorprothixene—Nortriptyline—CYP2D6—Parkinson's disease	5.55e-05	0.00819	CrCbGaD
Chlorprothixene—Chlorpromazine—DRD2—Parkinson's disease	5.51e-05	0.00814	CrCbGaD
Chlorprothixene—Promethazine—HTR2A—Parkinson's disease	5.5e-05	0.00812	CrCbGaD
Chlorprothixene—Amitriptyline—DRD2—Parkinson's disease	5.45e-05	0.00805	CrCbGaD
Chlorprothixene—Doxepin—HTR2A—Parkinson's disease	5.45e-05	0.00804	CrCbGaD
Chlorprothixene—Perphenazine—HTR2A—Parkinson's disease	5.37e-05	0.00793	CrCbGaD
Chlorprothixene—Chlorpromazine—CYP2E1—Parkinson's disease	5.31e-05	0.00783	CrCbGaD
Chlorprothixene—Amitriptyline—CYP2E1—Parkinson's disease	5.25e-05	0.00774	CrCbGaD
Chlorprothixene—Methotrimeprazine—CYP2D6—Parkinson's disease	5.11e-05	0.00754	CrCbGaD
Chlorprothixene—Promethazine—CYP2D6—Parkinson's disease	5.03e-05	0.00743	CrCbGaD
Chlorprothixene—Doxepin—CYP2D6—Parkinson's disease	4.98e-05	0.00735	CrCbGaD
Chlorprothixene—Perphenazine—CYP2D6—Parkinson's disease	4.91e-05	0.00725	CrCbGaD
Chlorprothixene—Promazine—HTR2A—Parkinson's disease	4.84e-05	0.00715	CrCbGaD
Chlorprothixene—Chlorpromazine—HTR2A—Parkinson's disease	4.26e-05	0.00629	CrCbGaD
Chlorprothixene—Amitriptyline—HTR2A—Parkinson's disease	4.21e-05	0.00622	CrCbGaD
Chlorprothixene—Clomipramine—ABCB1—Parkinson's disease	4.06e-05	0.00599	CrCbGaD
Chlorprothixene—Chlorpromazine—CYP2D6—Parkinson's disease	3.9e-05	0.00575	CrCbGaD
Chlorprothixene—Amitriptyline—CYP2D6—Parkinson's disease	3.85e-05	0.00569	CrCbGaD
Chlorprothixene—Flurazepam—ABCB1—Parkinson's disease	3.77e-05	0.00557	CrCbGaD
Chlorprothixene—Promethazine—ABCB1—Parkinson's disease	3.59e-05	0.0053	CrCbGaD
Chlorprothixene—Doxepin—ABCB1—Parkinson's disease	3.56e-05	0.00525	CrCbGaD
Chlorprothixene—Midazolam—ABCB1—Parkinson's disease	3.5e-05	0.00516	CrCbGaD
Chlorprothixene—Diazepam—ABCB1—Parkinson's disease	3e-05	0.00442	CrCbGaD
Chlorprothixene—Chlorpromazine—ABCB1—Parkinson's disease	2.78e-05	0.00411	CrCbGaD
Chlorprothixene—Amitriptyline—ABCB1—Parkinson's disease	2.75e-05	0.00406	CrCbGaD
Chlorprothixene—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	1.21e-05	8.93e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	1.21e-05	8.91e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—ADORA2A—Parkinson's disease	1.21e-05	8.89e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—EDN1—Parkinson's disease	1.2e-05	8.84e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—CTGF—Parkinson's disease	1.2e-05	8.83e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—DRD2—Parkinson's disease	1.2e-05	8.83e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—HTR7—Parkinson's disease	1.2e-05	8.83e-05	CbGpPWpGaD
Chlorprothixene—DRD2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.2e-05	8.82e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.19e-05	8.74e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—IGF2—Parkinson's disease	1.18e-05	8.71e-05	CbGpPWpGaD
Chlorprothixene—HRH1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.18e-05	8.66e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	1.17e-05	8.63e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.17e-05	8.62e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	1.17e-05	8.6e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—GPCR downstream signaling—HTR2A—Parkinson's disease	1.16e-05	8.52e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—INSR—Parkinson's disease	1.15e-05	8.49e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.15e-05	8.46e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—IGF1R—Parkinson's disease	1.14e-05	8.42e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.13e-05	8.36e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—INSR—Parkinson's disease	1.13e-05	8.34e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—EDN1—Parkinson's disease	1.13e-05	8.32e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—INSR—Parkinson's disease	1.13e-05	8.31e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—INSR—Parkinson's disease	1.12e-05	8.28e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—CYP2E1—Parkinson's disease	1.12e-05	8.23e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—IGF2—Parkinson's disease	1.12e-05	8.21e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—INSR—Parkinson's disease	1.11e-05	8.2e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—NQO1—Parkinson's disease	1.1e-05	8.14e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.1e-05	8.1e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—FGB—Parkinson's disease	1.09e-05	8.03e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—TH—Parkinson's disease	1.09e-05	8.02e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—HTR2A—Parkinson's disease	1.09e-05	8.01e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—HTR1A—Parkinson's disease	1.08e-05	7.98e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	1.08e-05	7.95e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—IGF1R—Parkinson's disease	1.08e-05	7.94e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.07e-05	7.9e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.07e-05	7.9e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—FGB—Parkinson's disease	1.07e-05	7.88e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—IGF2—Parkinson's disease	1.07e-05	7.87e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—TAC1—Parkinson's disease	1.07e-05	7.86e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—HTR2A—Parkinson's disease	1.07e-05	7.86e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.07e-05	7.86e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—FGB—Parkinson's disease	1.07e-05	7.85e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—EDN1—Parkinson's disease	1.07e-05	7.85e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—HTR1A—Parkinson's disease	1.06e-05	7.84e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	1.06e-05	7.84e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—FGB—Parkinson's disease	1.06e-05	7.83e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	1.06e-05	7.81e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	1.06e-05	7.81e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	1.06e-05	7.79e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.05e-05	7.76e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—FGB—Parkinson's disease	1.05e-05	7.75e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.05e-05	7.74e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—HTR2A—Parkinson's disease	1.05e-05	7.74e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—TAC1—Parkinson's disease	1.05e-05	7.72e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—HTR1A—Parkinson's disease	1.05e-05	7.71e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—DRD1—Parkinson's disease	1.05e-05	7.71e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—CYCS—Parkinson's disease	1.05e-05	7.7e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	1.04e-05	7.7e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	1.04e-05	7.69e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—MAOB—Parkinson's disease	1.04e-05	7.68e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	1.04e-05	7.67e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.04e-05	7.65e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.04e-05	7.65e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—NGF—Parkinson's disease	1.04e-05	7.65e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—IGF1R—Parkinson's disease	1.03e-05	7.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—TAC1—Parkinson's disease	1.03e-05	7.6e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	1.03e-05	7.59e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.03e-05	7.59e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—DRD1—Parkinson's disease	1.03e-05	7.57e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	1.02e-05	7.55e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	1.02e-05	7.52e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—EDN1—Parkinson's disease	1.02e-05	7.52e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—IGF2—Parkinson's disease	1.02e-05	7.5e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—DRD3—Parkinson's disease	1.01e-05	7.47e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—DRD1—Parkinson's disease	1.01e-05	7.45e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—IGF2—Parkinson's disease	1e-05	7.4e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	9.97e-06	7.35e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—DRD3—Parkinson's disease	9.95e-06	7.33e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	9.92e-06	7.31e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	9.89e-06	7.29e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	9.88e-06	7.28e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—IGF1R—Parkinson's disease	9.84e-06	7.25e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—DRD3—Parkinson's disease	9.79e-06	7.21e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—NGF—Parkinson's disease	9.79e-06	7.21e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—EDN1—Parkinson's disease	9.72e-06	7.16e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	9.71e-06	7.15e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—EDN1—Parkinson's disease	9.59e-06	7.07e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—NGF—Parkinson's disease	9.47e-06	6.98e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—ADRBK1—Parkinson's disease	9.47e-06	6.97e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—NGF—Parkinson's disease	9.38e-06	6.91e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—HTR2A—Parkinson's disease	9.32e-06	6.87e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	9.31e-06	6.86e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—ADRBK1—Parkinson's disease	9.29e-06	6.85e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	9.26e-06	6.82e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—COMT—Parkinson's disease	9.26e-06	6.82e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	9.23e-06	6.8e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—GSTP1—Parkinson's disease	9.21e-06	6.79e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—MAOA—Parkinson's disease	9.19e-06	6.77e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—APOE—Parkinson's disease	9.18e-06	6.77e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—HTR7—Parkinson's disease	9.17e-06	6.75e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—ADRBK1—Parkinson's disease	9.15e-06	6.74e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—HMOX1—Parkinson's disease	9.08e-06	6.69e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	9.02e-06	6.65e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	9.02e-06	6.65e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	9.02e-06	6.64e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—DRD2—Parkinson's disease	9e-06	6.63e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—HTR7—Parkinson's disease	9e-06	6.63e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	8.97e-06	6.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	8.97e-06	6.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	8.94e-06	6.59e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	8.94e-06	6.59e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—NGF—Parkinson's disease	8.93e-06	6.58e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—HTR2A—Parkinson's disease	8.92e-06	6.57e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—DRD2—Parkinson's disease	8.86e-06	6.52e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—HTR7—Parkinson's disease	8.86e-06	6.52e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—NGF—Parkinson's disease	8.81e-06	6.49e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—ABCB1—Parkinson's disease	8.72e-06	6.42e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	8.71e-06	6.41e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—APOE—Parkinson's disease	8.66e-06	6.38e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—HTR2A—Parkinson's disease	8.5e-06	6.27e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—GSTM1—Parkinson's disease	8.46e-06	6.24e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	8.42e-06	6.2e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	8.39e-06	6.18e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—APOE—Parkinson's disease	8.38e-06	6.18e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	8.32e-06	6.13e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—APOE—Parkinson's disease	8.3e-06	6.11e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—GPX1—Parkinson's disease	8.11e-06	5.97e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—APOE—Parkinson's disease	7.91e-06	5.82e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—INS—Parkinson's disease	7.85e-06	5.78e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—APOE—Parkinson's disease	7.8e-06	5.75e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CYP2D6—Parkinson's disease	7.75e-06	5.71e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—IGF2—Parkinson's disease	7.68e-06	5.66e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—NGF—Parkinson's disease	7.64e-06	5.63e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CTGF—Parkinson's disease	7.61e-06	5.6e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	7.56e-06	5.57e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—IGF2—Parkinson's disease	7.54e-06	5.56e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	7.52e-06	5.54e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	7.49e-06	5.52e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—MTHFR—Parkinson's disease	7.48e-06	5.51e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—IGF1R—Parkinson's disease	7.43e-06	5.47e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—IGF2—Parkinson's disease	7.42e-06	5.47e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—INS—Parkinson's disease	7.4e-06	5.45e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—EDN1—Parkinson's disease	7.34e-06	5.41e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	7.31e-06	5.38e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—IGF1R—Parkinson's disease	7.29e-06	5.37e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	7.28e-06	5.36e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	7.27e-06	5.36e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	7.25e-06	5.34e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	7.22e-06	5.32e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—EDN1—Parkinson's disease	7.21e-06	5.31e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	7.18e-06	5.29e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—IGF1R—Parkinson's disease	7.18e-06	5.29e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—INS—Parkinson's disease	7.16e-06	5.28e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	7.16e-06	5.27e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—EDN1—Parkinson's disease	7.09e-06	5.22e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—INS—Parkinson's disease	7.09e-06	5.22e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CYP2E1—Parkinson's disease	7.09e-06	5.22e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—NQO1—Parkinson's disease	7.01e-06	5.16e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—APOE—Parkinson's disease	6.96e-06	5.13e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—TH—Parkinson's disease	6.91e-06	5.09e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—APOE—Parkinson's disease	6.76e-06	4.98e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—INS—Parkinson's disease	6.75e-06	4.98e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—NGF—Parkinson's disease	6.74e-06	4.97e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—INS—Parkinson's disease	6.66e-06	4.91e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—NGF—Parkinson's disease	6.64e-06	4.89e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—CYCS—Parkinson's disease	6.63e-06	4.88e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—NGF—Parkinson's disease	6.62e-06	4.88e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—NGF—Parkinson's disease	6.6e-06	4.86e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—NGF—Parkinson's disease	6.58e-06	4.85e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—NGF—Parkinson's disease	6.52e-06	4.8e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	6.42e-06	4.73e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	6.3e-06	4.64e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	6.28e-06	4.63e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	6.26e-06	4.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	6.2e-06	4.57e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—APOE—Parkinson's disease	5.97e-06	4.4e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Metabolism—INS—Parkinson's disease	5.95e-06	4.38e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—APOE—Parkinson's disease	5.87e-06	4.33e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—COMT—Parkinson's disease	5.87e-06	4.33e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—APOE—Parkinson's disease	5.86e-06	4.32e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—GSTP1—Parkinson's disease	5.84e-06	4.31e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—APOE—Parkinson's disease	5.84e-06	4.3e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—CASP3—Parkinson's disease	5.84e-06	4.3e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—MAOA—Parkinson's disease	5.83e-06	4.3e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—APOE—Parkinson's disease	5.82e-06	4.29e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling by GPCR—IL6—Parkinson's disease	5.8e-06	4.28e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—INS—Parkinson's disease	5.78e-06	4.26e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—APOE—Parkinson's disease	5.77e-06	4.25e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—HMOX1—Parkinson's disease	5.76e-06	4.25e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	5.51e-06	4.06e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	5.48e-06	4.03e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—GSTM1—Parkinson's disease	5.37e-06	3.96e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	5.37e-06	3.96e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	5.33e-06	3.93e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	5.3e-06	3.9e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	5.28e-06	3.89e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	5.24e-06	3.86e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—GPX1—Parkinson's disease	5.14e-06	3.79e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—INS—Parkinson's disease	5.1e-06	3.76e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	5.06e-06	3.73e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—CASP3—Parkinson's disease	5.03e-06	3.7e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—INS—Parkinson's disease	5.02e-06	3.7e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—INS—Parkinson's disease	5.01e-06	3.69e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling by GPCR—IL6—Parkinson's disease	5e-06	3.68e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—INS—Parkinson's disease	4.99e-06	3.68e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—INS—Parkinson's disease	4.98e-06	3.66e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—CASP3—Parkinson's disease	4.96e-06	3.66e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling by GPCR—IL6—Parkinson's disease	4.93e-06	3.63e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—INS—Parkinson's disease	4.93e-06	3.63e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	4.9e-06	3.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	4.85e-06	3.57e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—MTHFR—Parkinson's disease	4.75e-06	3.5e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—MAPK8—Parkinson's disease	4.62e-06	3.4e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	4.56e-06	3.36e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—APOE—Parkinson's disease	4.42e-06	3.26e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	4.3e-06	3.17e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	4.27e-06	3.15e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	3.95e-06	2.91e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—CASP3—Parkinson's disease	3.8e-06	2.8e-05	CbGpPWpGaD
Chlorprothixene—ABCB1—Metabolism—INS—Parkinson's disease	3.78e-06	2.78e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling by GPCR—IL6—Parkinson's disease	3.77e-06	2.78e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	3.74e-06	2.75e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—CASP3—Parkinson's disease	3.73e-06	2.75e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	3.72e-06	2.74e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	3.71e-06	2.73e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	3.7e-06	2.73e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling by GPCR—IL6—Parkinson's disease	3.7e-06	2.73e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	3.69e-06	2.72e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	3.68e-06	2.71e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	3.67e-06	2.7e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	3.64e-06	2.68e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	3.49e-06	2.57e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.43e-06	2.53e-05	CbGpPWpGaD
Chlorprothixene—HTR6—Signaling Pathways—IL6—Parkinson's disease	3.43e-06	2.53e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	3.43e-06	2.52e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	3.42e-06	2.52e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	3.4e-06	2.51e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	3.37e-06	2.48e-05	CbGpPWpGaD
Chlorprothixene—CHRM4—Signaling Pathways—IL6—Parkinson's disease	3.23e-06	2.38e-05	CbGpPWpGaD
Chlorprothixene—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.13e-06	2.31e-05	CbGpPWpGaD
Chlorprothixene—CHRM5—Signaling Pathways—IL6—Parkinson's disease	3.1e-06	2.28e-05	CbGpPWpGaD
Chlorprothixene—DRD1—Signaling Pathways—IL6—Parkinson's disease	2.95e-06	2.17e-05	CbGpPWpGaD
Chlorprothixene—DRD3—Signaling Pathways—IL6—Parkinson's disease	2.91e-06	2.15e-05	CbGpPWpGaD
Chlorprothixene—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.52e-06	1.86e-05	CbGpPWpGaD
Chlorprothixene—DRD2—Signaling Pathways—IL6—Parkinson's disease	2.23e-06	1.64e-05	CbGpPWpGaD
Chlorprothixene—HTR2A—Signaling Pathways—IL6—Parkinson's disease	2.19e-06	1.62e-05	CbGpPWpGaD
Chlorprothixene—HRH1—Signaling Pathways—IL6—Parkinson's disease	2.19e-06	1.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM1—Signaling Pathways—IL6—Parkinson's disease	2.18e-06	1.61e-05	CbGpPWpGaD
Chlorprothixene—CHRM3—Signaling Pathways—IL6—Parkinson's disease	2.17e-06	1.6e-05	CbGpPWpGaD
Chlorprothixene—CHRM2—Signaling Pathways—IL6—Parkinson's disease	2.15e-06	1.59e-05	CbGpPWpGaD
